Does DACOMITINIB Cause Mucosal inflammation? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Mucosal inflammation have been filed in association with DACOMITINIB (Vizimpro). This represents 3.1% of all adverse event reports for DACOMITINIB.
21
Reports of Mucosal inflammation with DACOMITINIB
3.1%
of all DACOMITINIB reports
6
Deaths
3
Hospitalizations
How Dangerous Is Mucosal inflammation From DACOMITINIB?
Of the 21 reports, 6 (28.6%) resulted in death, 3 (14.3%) required hospitalization, and 1 (4.8%) were considered life-threatening.
Is Mucosal inflammation Listed in the Official Label?
Yes, Mucosal inflammation is listed as a known adverse reaction in the official FDA drug label for DACOMITINIB.
What Other Side Effects Does DACOMITINIB Cause?
Death (253)
Diarrhoea (114)
Rash (108)
Neoplasm progression (78)
Paronychia (55)
Blood pressure increased (47)
Off label use (35)
Pruritus (34)
Dyspnoea (30)
Carcinoembryonic antigen increased (28)
What Other Drugs Cause Mucosal inflammation?
METHOTREXATE (3,352)
CYCLOPHOSPHAMIDE (2,535)
DOXORUBICIN (1,939)
VINCRISTINE (1,594)
ETOPOSIDE (1,591)
FLUOROURACIL (1,481)
RITUXIMAB (1,364)
CYTARABINE (1,337)
CAPECITABINE (1,262)
CARBOPLATIN (1,259)
Which DACOMITINIB Alternatives Have Lower Mucosal inflammation Risk?
DACOMITINIB vs DACTINOMYCIN
DACOMITINIB vs DALBAVANCIN
DACOMITINIB vs DALFAMPRIDINE
DACOMITINIB vs DALTEPARIN
DACOMITINIB vs DAMOCTOCOG ALFA PEGOL